We've moved! Same resources, new address:

Find resources

Total results with these characteristics: 365

Topic: Disease burden and surveillance

Page 8 of 19
High Disease Burden of Diarrhea Due to Enterotoxigenic Escherichia coli Among Rural Egyptian Infants and Young Children

Published in the Journal of Clinical Microbiology, this article examines the burden of diarrheal disease due to enterotoxigenic E. coli among rural Egyptian infants and young children, which has an incidence of 1.5 episodes per child per year and …

Author: Rao M, Abu-Elyazeed R, Savarino S, et al.

Publication date: 2003

High Rates of Enteric Fever Diagnosis and Lower Burden of Culture-Confirmed Disease in Peri-Urban and Rural Nepal

Existing data on enteric fever in South Asia is mostly derived from urban areas. This article, published in the Journal of Infectious Diseases, characterizes enteric disease diagnosis, treatment practices, and the true burden of enteric fever among …

Author: Andrews JR, Vaidya K, Bern C, et al.

Publication date: 2017

A History of Vaccines

This fact sheet on the history of vaccines gives a brief overview of disease rates before and after the development of vaccines.

Author: PATH

Publication date: 2015

How Can Data Help Fight Disease?

This animated video explains the important role that data plays in fighting polio worldwide. Data about cases of polio, the size of an outbreak and the population affected, and information about vaccination programs can be collected and shared …

Author: Bill & Melinda Gates Foundation

Publication date: 2016

HPV Vaccine Infographic 2014

This infographic provides information on the scale of cervical cancer deaths around the world. It also distinguishes between countries with national human papillomavirus (HPV) vaccine programs and countries that are eligible for HPV vaccine funding …

Author: GAVI Alliance

Publication date: 2014

Human Immunity to the Meningococcus: Development of Natural Immunity

This article, published in the Journal of Experimental Medicine, discusses a study in the United States that suggests that natural immunity to meningococcal disease is initiated, reinforced, and broadened by intermittent carriage of different …

Author: Goldschneider I, Gotschlich EC, Artenstein MS

Publication date: 1969

Human Immunity to the Meningococcus: The Role of Humoral Antibodies

This article, published in the Journal of Experimental Medicine, reviews an earlier study of the age-specific incidence of meningococcal meningitis in the United States that found that the proportion of individuals with serum bactericidal …

Author: Goldschneider I, Gotschlich EC, Artenstein MS

Publication date: 1969

Human Papillomavirus (HPV)

The US Centers for Disease Control and Prevention provides this web page to offer a wide spectrum of information about human papillomavirus (HPV) in the United States. It offers a general overview of the disease, as well as prevention and treatment …

Author: US Centers for Disease Control and Prevention

Human Papillomavirus (HPV)

This web page provides an overview of HPV and the vaccines against it. This page also provides links to World Health Organization (WHO) position papers on HPV, disease burden information, and other related WHO resources.

Author: World Health Organization

A Hypothetical Explanatory Model for Meningococcal Meningitis in the African Meningitis Belt

Currently, no explanation exists for the epidemic pattern of meningitis in the African meningitis belt, in spite of recent progress in disease surveillance. Such a model would be conducive to mathematically mapping vaccine strategies or predicting …

Author: Mueller JE, Gessner BD

Publication date: 2010

ICO (Institut Català d'Oncologia) Information Centre on HPV and Cancer

This information center was developed to accelerate the development and introduction of prophylactic HPV vaccines in countries with the highest burden of cervical cancer and reduce the incidence of this disease and related lesions among women. It …

Author: Institut Català d’Oncologia

Immunization Coverage

This fact sheet provides an overview of global immunization coverage based on the latest World Health Organization and United Nations Children's Fund estimates. It includes data on deaths averted due to immunization in general, as well as figures …

Author: World Health Organization, United Nations Children's Fund

Publication date: 2017

Immunization Surveillance, Assessment and Monitoring

This web page provides up-to-date information on regional and global incidence of vaccine-preventable diseases, as well as rates of immunization coverage. Most of the data is derived from official reports by World Health Organization (WHO) Member …

Author: World Health Organization

Impact of MenAfriVac in Nine Countries of the African Meningitis Belt, 2010–15: An Analysis of Surveillance Data

This article, published in The Lancet Infectious Diseases, analyzes surveillance data from nine countries on suspected and confirmed cases of meningitis to quantify the impact of MenAfriVac®, a meningococcal group A conjugate vaccine. The authors …

Author: Trotter CL, Lingani C, Fernandez K, et al.

Publication date: 2017

Impact of Rotavirus Vaccination in Germany: Rotavirus Surveillance, Hospitalization, Side Effects and Comparison of Vaccines

This article, published in the Pediatric Infectious Disease Journal, examines the impact of national introduction of rotavirus vaccination in Germany. Rotavirus-related hospital admissions of children under one year of age decreased by 60 percent in …

Author: Uhlig U, Kostev K, Schuster V, Koletzko S, Uhlig HH

Publication date: 2014

Impact of Rotavirus Vaccine on All-Cause Diarrhea and Rotavirus Hospitalizations in Madagascar

This article, published in Vaccine, reports on an observational study which found that after implementation of rotavirus vaccine introduction in Madagascar in 2014, diarrhea hospitalizations in children younger than five years of age decreased by 36 …

Author: Rahajamanana VL, Raboba JL, Rakotozanany A, et al.

Publication date: 2017

Impact of the Serogroup A Meningococcal Conjugate Vaccine, MenAfriVac, on Carriage and Herd Immunity

The conjugate vaccine against serogroup A Neisseria meningitidis (NmA), MenAfriVac, was first introduced in mass vaccination campaigns of 1 to 29-year-olds in Burkina Faso in 2010. The authors of this article, published in Clinical Infectious …

Author: Kristiansen PA, Diomandé F, Ba AK, et al.

Publication date: 2013

Improving Global Health by Preventing Pneumococcal Disease

This report summarizes the results of a six-month inquiry by the UK All-Party Parliamentary Group for Pneumococcal Disease Prevention in the Developing World (APPG) on the global disease burden of pneumococcal disease and pneumonia, …

Author: UK All-Party Parliamentary Group on Pneumococcal Disease Prevention in the Developing World

Publication date: 2008

Incidence of Invasive Salmonella Disease in Sub-Saharan Africa: A Multicentre Population-Based Surveillance Study

This article, published in The Lancet Global Health, reports the results of a study that aimed to measure incidence estimates of typhoid fever and invasive non-typhoidal salmonella (iNTS) disease in sub-Saharan Africa. Using data from 13 African …

Author: Marks F, von Kalckreuth V, Aaby P, et al.

Publication date: 2017

Incidence of Rotavirus and Circulating Genotypes in Northeast Brazil During 7 Years of National Rotavirus Vaccination

This article, published in PLoS One, examined rates of rotavirus infection before and after rotavirus vaccine introduction in Brazil in 2006. The authors found that the vaccine was associated with substantial reductions in rotavirus incidence and …

Author: Gurgel RQ, Alvarez AJ, Rodrigues A, et al.

Publication date: 2014

Page 8 of 19